ArticleInternational journal of molecular sciences2025

Targeting Metabolic and Epigenetic Vulnerabilities in Glioblastoma with SN-38 and Rabusertib Combination Therapy.

Jennifer Chiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.